Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Concordance with CONSORT-AI guidelines in reporting of randomised controlled trials investigating artificial intelligence in oncology: a systematic review
3
Zitationen
5
Autoren
2025
Jahr
Abstract
Although the majority of CONSORT and CONSORT-AI items were well-reported, critical gaps related to reporting of methodology, reproducibility and harms persist. Addressing these gaps through consideration of trial design to mitigate risks of bias coupled with standardised reporting is one step towards responsible adoption of AI to improve patient outcomes in oncology.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.250 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.109 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.482 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.434 Zit.